Antibody which is directed against galectin-9 and is an inhibitor of the suppressor activity of regulatory t lymphocytes
AssigneesUniversite Sciences Technologies Lille, Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy, Cellvax, Universite du Droit et de la Sante Lille 2, Universite Paris-Sud
InventorsNadira Delhem, Pierre Busson, Olivier Morales, Clement Barjon, Dhafer Mrizak, Claire Lhuillier, Rami Mustapha
Life of this patent
Estimating the term…
Abstract
The invention relates to an antibody which is directed against galectin-9 and is an inhibitor of the suppressor activity of regulatory T lymphocytes, and also to the use of this antibody for the treatment of diseases associated with the suppressor activity of regulatory T lymphocytes, in particular the treatment of cancer.
Claims17
An antibody directed against Galectin-9 and inhibiting the suppressor activity of regulatory T lymphocytes.
9-12. (canceled)
Dependencies are inferred from the claim text.